These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16076586)

  • 1. Twelve-month outcomes for heroin dependence treatments: does route of administration matter?
    Darke S; Ross J; Teesson M
    Drug Alcohol Rev; 2005 Mar; 24(2):165-71. PubMed ID: 16076586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking heroin with cannabis versus injecting heroin: unexpected impact on treatment outcomes.
    Morgan N; Daniels W; Subramaney U
    Harm Reduct J; 2019 Dec; 16(1):65. PubMed ID: 31805971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of major depression and drug-related problems amongst heroin users across 36 months.
    Darke S; Mills K; Teesson M; Ross J; Williamson A; Havard A
    Psychiatry Res; 2009 Mar; 166(1):7-14. PubMed ID: 19215987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence.
    Williamson A; Darke S; Ross J; Teesson M
    Drug Alcohol Depend; 2006 Feb; 81(3):293-300. PubMed ID: 16154714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors.
    Griffiths P; Gossop M; Powis B; Strang J
    Addiction; 1994 Mar; 89(3):301-9. PubMed ID: 8173499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How constant is an individual's route of heroin administration? Data from treatment and non-treatment samples.
    Strang J; Griffiths P; Powis B; Abbey J; Gossop M
    Drug Alcohol Depend; 1997 Jun; 46(1-2):115-8. PubMed ID: 9246559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Williamson A; Darke S; Ross J; Teesson M
    Drug Alcohol Rev; 2006 Mar; 25(2):141-8. PubMed ID: 16627303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment.
    Gossop M; Stewart D; Marsden J; Kidd T; Strang J
    Addict Behav; 2004 Aug; 29(6):1085-94. PubMed ID: 15236809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence.
    Darke S; Hetherington K; Ross J; Lynskey M; Teesson M
    Drug Alcohol Rev; 2004 Jun; 23(2):177-83. PubMed ID: 15370024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors.
    Darke S; Ross J; Lynskey M; Teesson M
    Drug Alcohol Depend; 2004 Jan; 73(1):1-10. PubMed ID: 14687954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome.
    Smolka M; Schmidt LG
    Addiction; 1999 Aug; 94(8):1191-8. PubMed ID: 10615734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of an 18-month, NHS-based, treatment exposure for heroin dependence: results from the London Area Treat 2000 Study.
    Schifano F; Martinotti G; Cunniff A; Reissner V; Scherbaum N; Ghodse H
    Am J Addict; 2012; 21(3):268-73. PubMed ID: 22494230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels and correlates of polydrug use among heroin users and regular amphetamine users.
    Darke S; Hall W
    Drug Alcohol Depend; 1995 Oct; 39(3):231-5. PubMed ID: 8556972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective observational study of heroin users in Johannesburg, South Africa: Assessing psychiatric comorbidities and treatment outcomes.
    Morgan N; Daniels W; Subramaney U
    Compr Psychiatry; 2019 Nov; 95():152137. PubMed ID: 31669789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes over time in heroin and cocaine use among injecting drug users in Amsterdam, The Netherlands, 1985-1989.
    Hartgers C; Van den Hoek A; Krijnen P; Van Brussel GH; Coutinho RA
    Br J Addict; 1991 Sep; 86(9):1091-7. PubMed ID: 1932880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of psychopathology and the relationship between routes of drug administration and psychiatric symptoms in heroin addicts.
    Wang QL; Liu ZM
    Subst Abus; 2012; 33(2):130-7. PubMed ID: 22489585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Heckathorn DD; Mcknight C; Bramson H; Friedman SR
    Addiction; 2007 May; 102(5):778-85. PubMed ID: 17506155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia.
    Humeniuk R; Ali R; McGregor C; Darke S
    Addiction; 2003 Apr; 98(4):413-8. PubMed ID: 12653811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.
    Hakansson A; Medvedeo A; Andersson M; Berglund M
    Eur Addict Res; 2007; 13(4):207-15. PubMed ID: 17851242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.